References
- Dorwart M, Thibodeau P, Thomas P. Cystic fibrosis: recent structural insights. J Cyst Fibros. 2004;3:91–94.10.1016/j.jcf.2004.05.020
- Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev. 2002;54:1359–1371.10.1016/S0169-409X(02)00144-8
- LiPuma J. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23:299–323.10.1128/CMR.00068-09
- de Vrankrijker AM, Wolfs TFW, van der Ent CK. Challenging and emerging pathogens in cystic fibrosis. Paediatr Respir Rev. 2010;11:246–254.10.1016/j.prrv.2010.07.003
- Westwood T, Henderson B, Ramsay M. Diagnosing cystic fibrosis in South Africa. S Afr Med J. 2006 April;96(4):304.
- CLSI M100-S16. Vol. 26 No.3. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement.
- CLSI M100-S17. Vol. 27 No.1. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement.
- CLSI M100-S18. Vol. 28 No.1. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement.
- CLSI M100-S19. Vol. 29 No.3. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement.
- CLSI M100-S20. Vol. 30 No.1. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement.
- Razvi S, Quittell L, Sewall A, et al. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 2009;136:1554–1560.10.1378/chest.09-0132
- Pentz A, Becker P, Masekela R, et al. The impact of chronic pseudomonal infection on pulmonary function testing in individuals with cystic fibrosis in Pretoria, South Africa. S Afr Med J. 2014;104(3):191–194.10.7196/samj.7222
- Valenza G, Tappe D, Turnwald D, et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros. Johannesburg: South African Cystic Fibrosis Association 2008;7:123–127.10.1016/j.jcf.2007.06.006
- Lambiase A, Raia V, Pezzo M, et al. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis. 2006;6(1):4.10.1186/1471-2334-6-4
- Millar FA, Simmonds NJ, Hodson ME. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005. J Cyst Fibros. 2009;8:386–391.10.1016/j.jcf.2009.08.003
- South African Cystic Fibrosis Consensus Group. The South African Cystic Fibrosis Consensus Document. 4th ed.. 2012.
- von Gottberg A, Cohen C, Whitelaw A, et al. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003–2009. Vaccine. 2012;30:565–571.10.1016/j.vaccine.2011.11.066
- Cystic Fibrosis Foundation Patient Registry. Annual Data Report. MD: Bethesda; 2008.
- Hansen C. Stenotrophomonas maltophilia. Curr Opin Pulmonary Med. 2012;18:628–631.10.1097/MCP.0b013e328358d4f8
- Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22:582–610.10.1128/CMR.00040-09
- Fortuin-de Smidt MC. Trends and Factors associated with invasive non-typeable and serotype b Haemophilus influenza disease in persons of all ages in South Africa from 2003–2009.Johannesburg: Department of Public Health, Master’s Degree Dissertation Report, University of the Witwatersrand; 2013.
- Bragonzi A, Farulla I, Paroni M, et al. Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS ONE. 2012;7:e52330.10.1371/journal.pone.0052330
- Sagel SD, Gibson RL, Emerson J, et al. Impact of pseudomonas and staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Paediatr. 2009;154:183–188.e3.10.1016/j.jpeds.2008.08.001
- Coenye T, Goris J, Spilker T, et al. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol. 2002;40:2062–2069.10.1128/JCM.40.6.2062-2069.2002
- Barillova P, Tchesnokova V, Dübbers A, et al. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients—An unrecognized CF pathogen? Int J Med Microbiol. 2014;304(3-4):415–421.10.1016/j.ijmm.2014.02.008
- Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis- a review. Med Mycol. 2009;47(4):387–397.10.1080/13693780802609604
- Jarzembowski JA, Young, MB. Nontuberculous mycobacterial infections. Arch Pathol Lab Med. 2008;132:1333–1341.
- Ciofu O, Hansen CR, Høiby N. Respiratory bacterial infections in cystic fibrosis. Curr Opin Pulmonary Med. 2013;19:251–258.10.1097/MCP.0b013e32835f1afc
- Boussaud V, Guillemain R, Grenet D, et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax. 2008;63:732–737.10.1136/thx.2007.089458